With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Lieber Institute for Brain Development have identified ...
New research finds that rates of GLP-1 use and misuse are shockingly high among people with a history of eating disorders.
With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.
This group may be taking the weight-loss drugs in contraindicated ways, researchers sugges ...